epirizole has been researched along with Arthritis, Rheumatoid in 1 studies
Epirizole: 4-Methoxy-2-(5-methoxy-3-methylpyrazol-1-yl)-6-methylpyrimidine. A pyrimidinyl pyrazole with antipyretic, analgesic, and anti-inflammatory activity.
Arthritis, Rheumatoid: A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gallo, M | 1 |
| La Montagna, G | 1 |
1 trial available for epirizole and Arthritis, Rheumatoid
| Article | Year |
|---|---|
[Controlled research on the use of epirizole in the therapy of rheumatoid arthritis].
Topics: Aged; Arthritis, Rheumatoid; Aspirin; Clinical Trials as Topic; Epirizole; Female; Humans; Male; Mid | 1983 |